Investor Relations

OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE more »

OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug Designations in Europe more »

OPKO Granted Patent from European Patent Office for Lagova™ more »

Strong Data from Lagova™ Phase II Clinical Study Presented during Webcast more »

Investor FAQs